Nu Skin Enterprises reported Q3 2024 revenue of $430.1 million, a decrease of 13.8% year-over-year, but within the guidance range. EPS was $0.17, compared to $(0.74) in the prior year, or $0.56 excluding an inventory write-off. The Rhyz segment continued to show strong growth, while the company focuses on strengthening the Nu Skin core business and improving profitability.
Revenue reached $430.1 million, reflecting a 13.8% decrease year-over-year.
Earnings per share (EPS) was $0.17, compared to $(0.74) in the prior-year quarter.
Rhyz revenue grew by 20.9% to $73.1 million.
The company is focused on strengthening the Nu Skin core, improving profitability, and optimizing the product portfolio.
Nu Skin anticipates Q4 2024 revenue to be between $410 to $445 million with EPS between $(0.09) to $0.01, or $0.19 to $0.29 non-GAAP. Full year 2024 revenue is projected to be $1.70 to $1.73 billion with EPS of $(2.32) to $(2.22), or $0.65 to $0.75 non-GAAP.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance